Ownership
Private
Therapeutic Areas
OncologyInfectious Diseases
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
CytokinesProtein therapeutics (platform for displaying functional cytokines)[3]

Vytokine Therapeutics General Information

Vytokine Therapeutics develops innovative medicines using a proprietary platform to display functional cytokines aimed at treating cancer and infectious diseases. No published clinical results as of now.[2][3][7]

Contact Information

Primary Industry
Biotech
Corporate Office
West Sacramento, California
United States

Drug Pipeline

No pipeline data available

For full access to Vytokine Therapeutics's pipeline data

Book a demo

Key Partnerships

No major pharmaceutical partnerships publicly disclosed as of current data. *Note*: Synthekine has Merck partnership but this does not apply to Vytokine Therapeutics.[6] *No evidence for academic collaborations or licensees in public sources.*

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Vytokine Therapeutics Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Vytokine Therapeutics's complete valuation and funding history, request access »

Vytokine Therapeutics Financial Metrics